Role of Aflatoxin B1 as a risk for primary liver cancer in north Indian population
Clinical Biochemistry, ISSN: 0009-9120, Vol: 44, Issue: 14, Page: 1235-1240
2011
- 44Citations
- 78Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations44
- Citation Indexes44
- 44
- CrossRef32
- Captures78
- Readers78
- 78
Article Description
The present study was designed to determine whether aflatoxin B1 (AFB1) exposure has any role to play in hepatocellular carcinoma (HCC) patients from northern India. A total of 266 HCC patients and 251 patients of chronic liver disease without-HCC were enrolled into the study. All samples were screened for serological markers for hepatitis B and C infections and levels of AFB1 in food and urine samples. A threefold (OR = 3.43) and five-fold (OR = 5.47) increased risk of HCC was observed amongst HBV infection and AFB1-levels in food and urine samples, respectively. However, a non-significant risk was observed with respect to HCV infection (OR = 1.27) and alcohol consumption (OR = 1.18). A threefold (OR = 3.15) increased risk of HCC was observed amongst cases of non-viral etiology with respect to urinary AFB1. The data provides an exposure and disease risk information for establishing intervention studies to diminish the impact of aflatoxin exposure in Indian population.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0009912011014561; http://dx.doi.org/10.1016/j.clinbiochem.2011.07.017; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=80052945113&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/21854762; https://linkinghub.elsevier.com/retrieve/pii/S0009912011014561; https://dx.doi.org/10.1016/j.clinbiochem.2011.07.017
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know